General Biotech

Designing the Biology of Tomorrow

General Biotech is a biotechnology research and development company focused on designing concepts, technologies and therapeutic systems at the intersection of biochemistry, molecular science, neuroscience and biomedical engineering.

We develop early-stage scientific programs with the objective of transforming biological problems into structured technological solutions capable of progressing toward experimental validation, clinical development and commercial partnership.

Research. Design. Translation.

Teal wireframe biological network merging into a molecular structure

Designing Biological Technologies

Biology is extraordinarily complex

Our objective is to understand that complexity well enough to design technologies around it. General Biotech develops scientific programs addressing challenges across human biology, from molecular therapeutics and neurochemistry to neuromuscular communication and biomedical systems.

  • Our work begins with a biological problem
  • We build the scientific architecture that turns an idea into a research program
  • Programs are prepared for validation, clinical development and partnership

Current Programs

Two active research programs

GB-102 — Neurochemical Therapeutic Architecture

Computationally designed therapeutic research

Computationally designed therapeutic research focused on neurochemical modulation and antidepressant activity, exploring how multiple molecular interactions could contribute to a broader therapeutic effect.

Status: Research & Development

GB-103 — Neuromuscular Interface Technology

More naturally controlled bionic prosthetics

Biomedical research focused on neuromuscular communication and the development of more naturally controlled bionic prosthetic systems, interpreting residual neuromuscular activity as prosthetic commands.

Status: Early Development

Explore our projects →

How We Develop

From Biological Problem to Research Program

General Biotech follows a structured development process, from the identification of a biological problem to the translation of a mature program into partnership.

01

Identify

We begin with a biological or medical problem where technological innovation could create meaningful improvement.

02

Investigate

Existing scientific literature, biological mechanisms, technologies and competing approaches are evaluated.

03

Design

A molecular architecture, biomedical system or technological concept is developed around the identified mechanism.

04

Model

Computational methods investigate molecular interactions, biological behaviour, engineering requirements or system performance.

05

Document

Scientific rationale, technical architecture, results, limitations and future requirements become structured documentation.

06

Validate

Projects requiring experimental development move toward collaboration with laboratories, clinical and engineering partners.

07

Translate

Projects with sufficient potential progress toward licensing, joint development or other strategic partnerships.

Our Mission

Transform Biological Understanding Into Technology

General Biotech operates across disciplines because many important biological problems cannot be solved within a single field.

01

Biochemistry

Understanding and manipulating molecular processes within biological systems.

02

Molecular Biology

Studying biological mechanisms at the molecular and cellular level.

03

Neuroscience

Investigating neural signaling, neurochemistry and nervous-system interaction.

04

Computational Biology

Using computational methods to evaluate biological interactions and guide research.

05

Biomedical Engineering

Translating biological signals and mechanisms into functional technologies.

Research Philosophy

Computational research is the beginning, not the conclusion

Computational biology makes it possible to explore biological systems before extensive physical experimentation. However, computational predictions remain predictions.

General Biotech distinguishes clearly between computational evidence, experimental evidence and clinical evidence. Scientific validation requires appropriate experimental and clinical research.

Discuss a Collaboration